Your search returned 39 studies. (Get alerts for new studies):
- Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for H
Conditions: B-cell Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Recurrent Small Lymphocytic Lymphoma - Refractory Chronic Lymphocytic Leukemia - Stage III Chronic Lymphocytic Leukemia - Stage III Small Lymphocytic Lymphoma - Stage IV Chronic Lymphocytic L
4 Locations available
- Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission
Conditions: B-cell Chronic Lymphocytic Leukemia - Recurrent Small Lymphocytic Lymphoma - Refractory Chronic Lymphocytic Leukemia
1 Location available
- Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Conditions: NHL - Lymphoma, Non-Hodgkin - Lymphoma, B-Cell - Lymphoma, Follicular - Lymphoma, Intermediate-Grade - Lymphoma, Large-Cell - Lymphoma, Low-Grade - Lymphoma, Mixed-Cell - Lymphoma, Small-Cell - Leukemia, Lymphocytic, Chronic - Leukemia, B-Cell, Chronic -
4 Locations available
- Oral Clofarabine for Relapsed/Refractory Indolent B-cell NHL and Mantle Cell Lymphoma
Conditions: Follicular Lymphoma - Marginal Zone Lymphoma - Mantle Cell Lymphoma - Small Lymphocytic Lymphoma - Lymphoplasmacytic Lymphoma - Low Grade B-cell Lymphoma, Not Otherwise Specified
2 Locations available
- Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
3 Locations available
- Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies
Conditions: Multiple Myeloma - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - Non Hodgkin's Lymphoma - Waldenstroms - Mantle Cell Lymphoma
1 Location available
- Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
1 Location available
- Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lympho
Conditions: Leukemia - Lymphoma
2 Locations available
- Lenalidomide and Rituximab in Treating Patients With Follicular or Small Lymphocytic Non-Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatm
Conditions: Lymphoma
1 Location available
- Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia - Contiguous Stage II Small Lymphocytic Lymphoma - Noncontiguous Stage II Small Lymphocytic Lymphoma - Stage I Chronic Lymphocytic Leukemia - Stage I Small Lymphocytic Lymphoma - Stage II Chronic Lymphocytic Leukemia -
2 Locations available
- Natural History Study of Monoclonal B Cell Lymphocytosis and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: B-Cell Chronic Lymphocytic Leukemia - Monoclonal B-Cell Lymphocytosis - Lymhoma, Small Lymphocytic - Chronic Lymphocytic Leukemia
1 Location available
- Phase I/II Study of B Cell Malignancies Using T Cells Expressing an Anti-CD19 Chimeric Receptor: Assessment of the Impact of Lymphocyte Depletion Prio
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma - Mantle Cell Lymphoma - Follicular Lymphoma - Large Cell Lymphoma
1 Location available
- Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Lymphocytic Leukemia
2 Locations available
- Bortezomib and Romidepsin in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
2 Locations available
- Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
10 Locations available
- A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-C
Conditions: Leukemia, Lymphocytic, Chronic, B-Cell - Chronic Lymphocytic Leukemia - Lymphoma, Small Lymphocytic
1 Location available
- Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
1 Location available
- Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Hematopoietic/Lymphoid Cancer - B-cell Chronic Lymphocytic Leukemia - Contiguous Stage II Small Lymphocytic Lymphoma - Noncontiguous Stage II Small Lymphocytic Lymphoma - Stage 0 Chronic Lymphocytic Leukemia - Stage I Chronic Lymphocytic Leukemia - Stage
4 Locations available
- Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
21 Locations available
- Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Leukemia
1 Location available
- Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
1 Location available
- Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leuke
Conditions: Leukemia - Lymphoma
1 Location available
- A Phase II Study of Ofatumumab-Based Induction Chemoimmunotheraphy Followed by Consolidation Ofatumumab Immunotherapy in Previously Untreated Patients
Conditions: Small Lymphocytic Lymphoma - CLL (Chronic Lymphocytic Leukemia)
1 Location available
- Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
2 Locations available
- Tandem Auto-Allo Transplant for Lymphoma
Conditions: Diffuse, Large B-Cell, Lymphoma - Lymphoma, Low-Grade - T-Cell Lymphoma - Mantle-Cell Lymphoma - Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Lymphoma, Small Lymphocytic
2 Locations available
- Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
Conditions: B-cell Chronic Lymphocytic Leukemia - Hematopoietic/Lymphoid Cancer - Prolymphocytic Leukemia - Recurrent Small Lymphocytic Lymphoma - Refractory Chronic Lymphocytic Leukemia
1 Location available
- Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
Conditions: Follicular Lymphoma - Marginal Zone Lymphoma - Small Lymphocytic Lymphoma
2 Locations available
- Study Examining the Combination of Lenalidomide and Azacitidine for Relapsed/Refractory CLL and SLL
Conditions: Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
1 Location available
- Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
Conditions: Leukemia
1 Location available
- Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
Conditions: Indolent Non-Hodgkin Lymphoma - Follicular Lymphoma - Small Lymphocytic Lymphoma - Lymphoplasmacytoid Lymphoma - Marginal Zone Lymphoma
24 Locations available
- Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Bacterial Infection - Leukemia - Lymphoma
1 Location available
- Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma - B Chronic Lymphocytic Leukemia
2 Locations available
- Phase II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia (CLL) - Small Lymphocytic Lymphoma - Leukemia, Prolymphocytic
1 Location available
- Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Pro
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
Conditions: Leukemia - Lymphoma
1 Location available
- Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
1 Location available
- Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic L
Conditions: Chronic Lymphocytic Leukemia (CLL) - Small Lymphocytic Lymphoma (SLL)
1 Location available
- PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Leukemia, Lymphocytyc - CLL (Chronic Lymphocytic Leukemia) - SLL (Small Lymphocytic Lymphoma)
1 Location available
- Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymp
Conditions: Leukemia - Lymphoma
1 Location available
|